𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease

✍ Scribed by Eliezer Masliah; Edward Rockenstein; Anthony Adame; Michael Alford; Leslie Crews; Makoto Hashimoto; Peter Seubert; Michael Lee; Jason Goldstein; Tamie Chilcote; Dora Games; Dale Schenk

Book ID
116782338
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
774 KB
Volume
46
Category
Article
ISSN
0896-6273

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of α-synuclein mRNA in Parkin
Expression of α-synuclein mRNA in Parkinson's disease
✍ Spiridon Papapetropoulos; Nikhil Adi; Deborah C. Mash; Lina Shehadeh; Nanette Bi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

The letter by Papapetropoulos and colleagues presents an additional study correlating ␣-synuclein expression levels and sporadic PD. Previously we and others published studies of mRNA levels of SNCA in PD brains that have been performed using different methods. Some are in agreement with our results

Dopamine receptor agonists reverse behav
Dopamine receptor agonists reverse behavioral abnormalities of α-synuclein transgenic mouse, a new model of Parkinson's disease
✍ Masaki Wakamatsu; Shingo Iwata; Takeo Funakoshi; Makoto Yoshimoto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

## Abstract Parkinson's disease (PD) is characterized by loss of nigral dopaminergic (DAergic) neurons and presence of Lewy bodies, whose major component is α‐synuclein. We had previously generated transgenic mice termed __Syn130m__ that express truncated human α‐synuclein (amino acid residues 1–13